Pneumococcal vaccines: who needs them and when?
Who needs pneumococcal vaccination?
Children and adults aged 65 or above are the main groups for pneumococcal vaccination. People with specified health risks should also discuss vaccination with a doctor; age alone does not settle the question.[1][2]
- Children: receive a pneumococcal conjugate vaccine through Hong Kong’s childhood programme, which routinely uses PCV15.
- Adults aged 65 or above: the government programme provides a vaccination pathway even without specified high-risk conditions. High-risk conditions change the vaccine combination, as shown in the schedule below.
- People with specified health risks: those under 65 can also discuss vaccination under local product instructions. Health conditions and previous doses determine the product and timing.
CHP’s specified high-risk conditions include:[1]
- Previous invasive pneumococcal disease, cerebrospinal fluid leakage or a cochlear implant.
- Chronic cardiovascular, lung, liver or kidney disease; hypertension without complications is excluded from this cardiovascular category.
- Metabolic conditions including diabetes or obesity, defined here as a body mass index (BMI) of 30 or above.
- Immunocompromised states related to conditions such as asplenia, HIV/AIDS, cancer treatment or steroid treatment.
- Chronic neurological conditions affecting breathing, handling respiratory secretions or self-care, or increasing the risk of aspiration.
Vaccination need and funding eligibility are separate. Eligible Hong Kong residents aged 65 or above can receive free or subsidised vaccination; others can ask about private vaccination. Bring any available vaccination records to help the doctor check whether another dose is needed, and which product and date to arrange.[1][2]
When are pneumococcal doses given?
| Hong Kong pathway | Starting arrangement | What needs checking |
|---|---|---|
Routine childhood programme | PCV15 at 2 and 4 months, followed by a booster at 12 months. | Ask the Maternal and Child Health Centre or doctor about missed doses or a different previous product. |
Eligible adults aged 65 or above, without specified high-risk conditions | One PPSV23 dose. | Previous vaccine names and dates. |
Eligible adults aged 65 or above, with specified high-risk conditions | PCV15 followed by PPSV23 one year later. | Previous doses may change the next vaccine and timing. |
PCV20 adult option — local product schedule, separate from the government rows above | Adults aged 18 or above: one dose of Prevenar 20. | The doctor checks previous pneumococcal doses and health before choosing the next product and timing; do not treat this as an automatic extra dose. |
PCV20 infant option — local product schedule, separate from the routine PCV15 programme | Three primary doses starting in early infancy: the first is usually at 2 months and may be given as early as 6 weeks, with at least 4 weeks between doses; a booster at 11–15 months. | This is a four-dose series. Later starts, missed doses, previous vaccines and special health conditions require a different record-based review. |
The first three rows describe the Hong Kong government programmes. The PCV20 rows follow its Hong Kong product information and describe another product option, not a change to the government-funded schedule. For previous doses or catch-up vaccination, bring the product names and dates so the clinician can work out the next dose.[1][2][3][5]
“High risk” has a specific definition in the programme. Ask the provider to check your diagnosis against the CHP list; having uncomplicated high blood pressure alone is excluded from its chronic cardiovascular disease category. Do not restart or add doses just because a newer product is available.[1]
How do conjugate vaccines (PCV) and polysaccharide vaccines (PPSV23) differ?
Pneumococcal vaccines help prevent illness caused by pneumococcus, a bacterium that can cause pneumonia and serious infections of the blood or tissues around the brain. They do not prevent every cause of pneumonia. The vaccine and timing depend on your age, health and previous doses.[1]
Both types use sugars from the outer capsule of pneumococcus to help the immune system recognise the bacterium. The main difference is whether those sugars are joined to a carrier protein.[5][8]
| Type | How it works | Why the distinction matters |
|---|---|---|
Conjugate vaccine (PCV) | The capsule sugars are linked to a carrier protein. This recruits additional immune help and supports immune memory—the ability to recognise the same bacterial component again and respond more quickly. | Can be used in infants; childhood courses include primary and booster doses. Adult PCV20 is a single-dose schedule, with the need for revaccination not established. Hong Kong’s high-risk older-adult PCV15 pathway still includes PPSV23 one year later.[1][3][5] |
Polysaccharide vaccine (PPSV23, also called 23vPPV) | Contains capsule sugars from 23 serotypes without a linked carrier protein. It does not produce the same immune-memory response as a conjugate vaccine. | Pure polysaccharide vaccines do not reliably stimulate an immune response in children under 2. PPSV23 is used in Hong Kong’s older-adult programme. Some people at particularly high risk of serious infection or with a potentially rapid decline in antibody levels may need revaccination.[9][10] |
PCV15, PCV20 and PCV21 are conjugate vaccine examples. Their numbers describe how many serotypes, or types of pneumococcus, they target. Vaccine type and serotype count are different features: the choice also depends on age, health and previous doses, rather than the higher number alone.[1][3][5][8]
Which product names might you see?
| Brand | Type | Company / certificate-holder reference |
|---|---|---|
Prevenar 13 | PCV13 — 13-valent conjugate | Pfizer |
Vaxneuvance | PCV15 — 15-valent conjugate | MSD (Merck) |
Prevenar 20 | PCV20 — 20-valent conjugate | Pfizer |
Pneumovax 23 | PPSV23 — 23-valent polysaccharide | MSD (Merck) |
Capvaxive | PCV21 — 21-valent conjugate | MSD (Merck) |
The product names below are reference examples. Each has its own age indications and schedule, so ask which product the clinic offers and whether it is in stock. The table is not an exhaustive list.[1][4]
Capvaxive was registered in Hong Kong on 18 May 2026 (HK-69102). For stock and government-programme access, check separately with the provider.[4]
What side effects are possible?
Reactions can occur, but they vary by vaccine and age. After PPSV23, mild soreness or swelling at the injection site usually settles within two days. Fever, muscle aches and more severe local reactions are uncommon.[1]
For PCV15, commonly reported reactions in adults include injection-site pain, tiredness, muscle pain and headache. In children under 2, common reactions include fever, irritability, sleepiness and injection-site pain.[1]
DH’s childhood PCV information describes occasional mild fever or local redness or swelling that gradually settles over a few days. For another product, ask the clinic about its usual reactions and recovery time.[3]
Tell the clinic about any previous severe reaction to a pneumococcal vaccine, a vaccine ingredient or a diphtheria-toxoid-containing vaccine before another dose. Seek immediate medical help for breathing difficulty or swelling of the lips or tongue after vaccination. Persistent fever or discomfort also needs medical advice.[1][3]
Does a higher valency always mean better protection?
Not necessarily. Valency is the number of serotypes a vaccine targets. Serotypes are different types of pneumococcus, and vaccines can target different sets—not simply a larger version of the same set.
The choice also depends on Hong Kong disease patterns, clinical evidence, your age, health and vaccination history. The existing explorer compares reported serotypes with vaccine reference sets. It does not measure protection or choose a vaccine for you.[1][6][7]
Hong Kong serotypes and vaccine coverage
Compare the serotypes covered by each vaccine and the cases reported for those serotypes in Hong Kong.
Serotypes covered by each vaccine and their reported cases
Total reported cases:96 cases✓ Covered: 62 cases · — Not covered: 22 cases · ≈ Cross-reactivity: 0 cases · ? Insufficient data: 12 cases
✓ Covered: 71 cases · — Not covered: 13 cases · ≈ Cross-reactivity: 0 cases · ? Insufficient data: 12 cases
✓ Covered: 68 cases · — Not covered: 12 cases · ≈ Cross-reactivity: 3 cases · ? Insufficient data: 13 cases
Serotype totals depend on the selected period. Serotypes with no reported cases are not counted.
PCV20 · Covered: 71 cases
- 3 (43 cases)
- 9V (3 cases)
- 14 (3 cases)
- 15B (3 cases)
- 19A (3 cases)
- 19F (3 cases)
- 7F (2 cases)
- 8 (2 cases)
- 10A (2 cases)
- 11A (2 cases)
- 22F (2 cases)
- 23F (2 cases)
- 6B (1 cases)
Does a flu vaccine replace a pneumococcal vaccine?
No. Flu and pneumococcal disease have different causes. Pneumococcal vaccines target pneumococcus; they do not prevent all pneumonia. Whether you need a pneumococcal dose depends on your record and health, even if you have already had a flu vaccine.[1]
For the separate timing question, see pneumococcal and flu vaccination on the same day.
Where can you get vaccinated in Hong Kong?
For routine childhood vaccination, contact a DH Maternal and Child Health Centre, or ask a private doctor about private vaccination. For the older-adult programme, check whether the clinic participates in the Vaccination Subsidy Scheme and whether you meet the conditions. Some designated public clinics serve existing patients or clients only. Adults receiving free or subsidised vaccination must register for eHealth.[2][3]
For a private appointment, ask which product is offered, whether your previous doses affect the appointment, and the total charge. Ask the provider separately about subsidy eligibility and current stock.
For the detailed access questions, see older-adult pneumococcal subsidies and pneumococcal vaccine costs.
Packages & prices
Each listing shows its last verification date. Confirm price and eligibility with the provider before booking.
- Dedicare Medical CentreClinicLast verified 24 Oct 2026HK$400Book on clinic site ↗
Human Health Medical GroupClinicLast verified 24 Oct 2026HK$1,400Book on clinic site ↗- CUHK Medical CentrePrivate hospitalLast verified 24 Oct 2026HK$1,466Book on clinic site ↗
Quality HealthCare Medical CentreClinicLast verified 24 Oct 2026HK$1,548Book on clinic site ↗
Gleneagles Hospital Hong KongPrivate hospitalLast verified 13 Oct 2026HK$1,990Book on clinic site ↗
Human Health Medical GroupClinicLast verified 24 Sept 2026Price needs reconfirmationBook on clinic site ↗
Prices and terms change often and many are limited-time promotions — confirm the current price and availability with the provider before booking. hkvaccines.com is independent: we take no payment for bookings or placement.
What should you take to the appointment?
- Your vaccination record, if available, including product names and dates.
- A list of health conditions, medicines and any previous severe vaccine reactions.
- Questions about the next dose, any interval and whether subsidy conditions apply.
Ask the doctor to write down which product was given and when another dose is due, if one is needed.
Sources
- CHP: Pneumococcal vaccination FAQ / 衞生防護中心:肺炎球菌疫苗接種常見問題 · Hong Kong · Original date: 2026-08-31 · Accessed: 2026-10-24
- CHP: Pneumococcal vaccination programme / 肺炎球菌疫苗接種計劃 · Hong Kong · Original date: 2026-08-31 · Accessed: 2026-10-24
- DH Family Health Service: Pneumococcal conjugate vaccine / 家庭健康服務:肺炎球菌結合疫苗 · Hong Kong · Original date: FHS leaflet Rev 2024; HTML revision not displayed · Accessed: 2026-10-24
- Drug Office: Capvaxive registration HK-69102 / 藥物辦公室:Capvaxive 註冊紀錄 · Hong Kong · Original date: Registration: 2026-05-18; page revision not displayed · Accessed: 2026-10-24
- Prevenar 20: Hong Kong prescribing information / Prevenar 20 香港產品資料 · Hong Kong · Original date: JUL 2024; public manufacturer-hosted HK label accessed 2026-10-24 · Accessed: 2026-10-24
- CHP: IPD vaccine serotype reference / CHP 疫苗血清型資料 · Hong Kong · Original date: Revision date not displayed in PDF; dated module last checked 2026-10-19 · Accessed: 2026-10-24
- CHP: IPD case data / CHP 侵入性肺炎球菌病個案數據 · Hong Kong · Original date: Existing module period Jul 2024–Aug 2026; no fresh dataset request
- CDC Pink Book: Principles of Vaccination / 美國 CDC:疫苗學原理 · United States — supplementary immunology only · Original date: 2024-03-22 web page; 14th edition published August 2021 · Accessed: 2026-10-24
- DH Drug Office: Pneumovax 23 revaccination notice / 藥物辦公室:Pneumovax 23 再次接種通知 · Hong Kong — historical local product advice · Original date: 2011-12-28 — historical local notice; current HK insert not obtained · Accessed: 2026-10-24
- MSD UK: Pneumovax 23 product information / MSD 英國:Pneumovax 23 產品資料 · United Kingdom — supplementary product information only · Original date: Text revised 2026-05-12; emc updated 2026-06-05 · Accessed: 2026-10-24
Editorial review is distinct from clinical review. Source and price checks are dated below. How sources are used
Related vaccines
Related questions
Prepare for your next conversation
Answer 6 to 7 short questions for a vaccine discussion list with reasons.
Start your vaccine planner ↗